SASislana Azevedo

Sislana Azevedo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sislana Azevedo has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lithium Chloride rescues Monensin-potentiated Wnt signaling inhibition in inflammatory bone loss in rats

    by Anderson Chagas, Sthefane Gomes, Denis Oliveira, Khalil Viana, Jennifer Chaves, Conceição Martins, Vanessa Costa, Gisele Angelino, Sislana Azevedo, Diego Almeida, et al.


  • Open Access

    Antiresorptive effect of a semisynthetic triterpene from Combretum leprosum Mart. on dexamethasone-induced osteoporosis in rats

    by L.R. Garcez, P. Goes, J.L.T. Cavalcante, S.A. da Costa, W.L.C. Ribeiro, K.M.A. Pereira, F.W.G. Costa, P.G.B. Silva, F.S.R. Carvalho, C.J.A. Silva-Filho, et al.

    Chronic use of glucocorticoids is one of the most common causes of osteoporosis. Triterpenes have a positive effect on bone metabolism, which encourages research into the anti-resorptive properties of these natural compounds. In this study, the anti-resorptive effect of the semisynthetic compound 3β,6β,16β-tripropionyloxylup-20(29)-ene (CL-P2), obtained from the natural lupane-type triterpene 3β,6β,16β-trihydroxylup-20(29)-ene (CL-1) isolated from Combretum leprosum Mart., was investigated in a glucocorticoid-induced osteoporosis (GIO) model in rats. GIO was induced by dexamethasone (7 mg/kg, im; 1×/week, 65 days). On the 36th day, treatment was started (gavage) with CL-P2 (0.01 or 0.1 mg/kg; 30 days). After this time interval, the rats were euthanized and the femurs and lumbar vertebrae were collected for analysis by microcomputed tomography (micro-CT), quantity and type of collagen (Picrosirius Red), micro-Raman spectrometry, and histomorphometric analysis using hematoxylin and eosin (H&E) staining. The organs were collected for toxicity analysis (HE). CL-P2 increased trabecular volume, number of trabeculae and bone mineral density as evidenced by micro-CT analysis in the third lumbar vertebra (L3), as well as the amount of total collagen and type I collagen in L2. In the analysis of the femurs, CL-P2 promoted an increase in the number of osteoblasts and osteocytes and a reduction in the number of osteoclasts, as well as change in the mineral composition of these bones, suggested by the increase in the carbonate-to-phosphate ratio (CTPR) identified by micro-Raman spectrometry. Histopathological analysis of the organs revealed the pre-clinical safety of CL-P2. CL-P2 had bone-protective benefits and may be a biotechnologically viable product as a supplemental therapy for GIO.